Barcelona, 2019 July, 29. - In line with the guidance disclosed on 2019/12/06 for the first half of 2019, Ercros has reached an ebitda of EUR 29.7 million and a net profit of EUR 10.5 million. These figures are lower than those obtained in the same period of 2018 (35.7% and 62.7%, respectively), however, we must note that in the first half of 2018, results were particularly high.
Profit declined due to the downward trend of the cycle in the chlorine-alkali sector, which began in mid-2018. Sales were up reaching EUR 345,446 thousand, 3.2% higher than in the same period of 2018, due to higher volumes after the addition of new capacity in chlorine and caustic soda, PVC, polyols and synthesis and fermentation of pharmaceutical products despite falling sales prices.
Barcelona, July 3, 2019. - In accordance with the provisions of article 228 of Royal Legislative Decree 4/2015, of October 23, which approves the revised text of the Securities Market Law, Ercros, S.A. (hereinafter “Ercros” or “the Company”), and in relation to relevant events No. 262474, on March 1, 2018, No. 266852, on June 15, 2018, and No. 279195, on June 14, 2019, by means of this letter, communicates the following:
On June 14, 2019, a reduction of share capital by the amount of 888,240 euros was approved by the annual general meeting (“AGM”) of the Company, through the amortization of the 2,960,800 shares held by the Company in treasury, of a nominal value of 0.30 euros each, representing 2.745% of the share capital.
Download document
Download document
| Ercros guarantees that the relevant events that appear on this website correspond exactly to those sent to the CNMV by the company and disseminated by that organisation. The relevant events preceding those included in this section are available on the website of the CNMV. |
.
 |
 |
